Maxime Derisbourg
Overview
Explore the profile of Maxime Derisbourg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derisbourg M, Leghay C, Chiappetta G, Fernandez-Gomez F, Laurent C, Demeyer D, et al.
Sci Rep
. 2015 May;
5:9659.
PMID: 25974414
Tau is a central player in Alzheimer's disease (AD) and related Tauopathies, where it is found as aggregates in degenerating neurons. Abnormal post-translational modifications, such as truncation, are likely involved...
2.
Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S, et al.
Neurobiol Aging
. 2014 May;
35(9):2079-90.
PMID: 24780254
Tau pathology found in Alzheimer's disease (AD) is crucial in cognitive decline. Epidemiologic evidences support that habitual caffeine intake prevents memory decline during aging and reduces the risk to develop...
3.
Fernandez-Gomez F, Jumeau F, Derisbourg M, Burnouf S, Tran H, Eddarkaoui S, et al.
J Vis Exp
. 2014 Apr;
(86).
PMID: 24747743
Two-dimensional gel electrophoresis (2DE) is a powerful tool to uncover proteome modifications potentially related to different physiological or pathological conditions. Basically, this technique is based on the separation of proteins...
4.
Van der Jeugd A, Vermaercke B, Derisbourg M, Lo A, Hamdane M, Blum D, et al.
J Alzheimers Dis
. 2013 Aug;
37(4):777-88.
PMID: 23948912
Age-related cognitive decline and neurodegenerative diseases are a growing challenge for society. Accumulation of tau pathology has been proposed to partially contribute to these impairments. This study provides a behavioral...
5.
Burnouf S, Martire A, Derisbourg M, Laurent C, Belarbi K, Leboucher A, et al.
Aging Cell
. 2012 Oct;
12(1):11-23.
PMID: 23082852
While the spatiotemporal development of Tau pathology has been correlated with occurrence of cognitive deficits in Alzheimer's patients, mechanisms underlying these deficits remain unclear. Both brain-derived neurotrophic factor (BDNF) and...
6.
Burnouf S, Belarbi K, Troquier L, Derisbourg M, Demeyer D, Leboucher A, et al.
Curr Alzheimer Res
. 2012 Jan;
9(4):406-10.
PMID: 22272617
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular accumulation of amyloid deposits and intracellular neurofibrillary tangles (NFT) composed of hyperphosphorylated Tau proteins. Brain-derived neurotrophic factor (BDNF) is a...